Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03626103 · ClinicalTrials.gov registry record · NA

Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents

A NA study of Depressive Disorder and Violence, sponsored by Rhode Island Hospital.

Active
Registry status
NA
Development phase
800
Enrollment target
2
Study locations

NCT03626103 is a NA study of Depressive Disorder and Violence that is active but no longer recruiting, run by Rhode Island Hospital. The registered enrollment target is 800 participants, above the 315-participant average among 47 other Depressive Disorder trials with a reported enrollment target (154% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03626103, a NA study of Depressive Disorder and Violence, is active but no longer recruiting, sponsored by Rhode Island Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
800 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this investigation is to test the efficacy of "iDOVE2" (a brief emergency department introductory session and longitudinal automated text-message depression prevention program for high-risk teens), and to determine the most potent and parsimonious combination of intervention components for preventing peer violence and depressive symptoms among at-risk youth.

Interventions

  • BEHAVIORAL + Brief ED Intervention (BI)
  • BEHAVIORAL + Text

Study Locations (2)

Connecticut

  • Yale New Haven Hospital - New Haven

Rhode Island

  • Rhode Island Hospital/Hasbro Children's Hospital - Providence

Trial Details

FieldValue
Enrollment Target 800 participants
Start Date 2018-08-01
Est. Completion 2025-02
Phase NA

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT03626103

The ClinicalTrials.gov registry entry for NCT03626103 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 315-participant average among 47 other Depressive Disorder trials with a reported enrollment target (154% higher). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which + Brief ED Intervention (BI) is the first listed.

NCT03626103 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT03626103 about?

NCT03626103 is a clinical study titled "Intervention to Prevent Peer Violence & Depressive Symptoms Among At-Risk Adolescents". The purpose of this investigation is to test the efficacy of "iDOVE2" (a brief emergency department introductory session and longitudinal automated text-message depression prevention program for high-risk teens), and to determine the most potent and parsimonious combination of intervention component...

What is the current status of trial NCT03626103?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2018-08-01. Estimated completion is 2025-02.

What conditions does trial NCT03626103 study?

This clinical trial studies the following conditions: Depressive Disorder, Violence.

What interventions are being tested in trial NCT03626103?

The interventions under investigation include: + Brief ED Intervention (BI) (BEHAVIORAL), + Text (BEHAVIORAL).

Who is sponsoring clinical trial NCT03626103?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03626103 being conducted?

This trial has 2 study locations across Connecticut, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.